Patent Category: Therapies
Small-molecule inhibitors of GRHL transcription factors for use in cancer treatment, especially colorectal cancer
Nitroxyl derivative of polyphenol, methods of its production and its application
12.07.2022
A description of the invention will be available after the patent application is published.
Nencki Institute is the co-applicant with University of Warsaw. University of Warsaw is the leader ...Engineered synthetic peptides, compositions containing them, and methods of their use in the treatment of malignant gliomas
07.06.2022
A description of the invention will be available after the patent application is published.
Nencki Institute is the sole applicant.
For more information contact Technology Transfer Office.Inhibitor of protein kinase D (PKD) for use in prevention or treatment of obesity and a pharmaceutical composition for such use
03.03.2021
Description of the invention will be available after the patent application is published.
The Nencki Institute is a co-applicant of the patent with University of Würzburg.
For more ...Dicarboximide derivative for use in the treatment of cancer
01.03.2021
Description of the invention will be available after the patent application is published.
The Nencki Institute is a co-applicant of the patent with Centre of Molecular and Macromolecular ...